ASND
Ascendis Pharma A/S Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website ascendispharma.com
- Employees(FY) 797
- ISIN US04351P1012
Performance
-3.26%
1W
-10.64%
1M
-3.85%
3M
+39.29%
6M
+6.34%
YTD
+40.65%
1Y
Profile
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company also develops TransCon Growth Hormone for treating pediatric GHD, adult GHD, and turner syndrome; TransCon Parathyroid Hormone for adult patients with hypoparathyroidism; and TransCon C-type natriuretic peptide for achondroplasia. In addition, it is developing TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/? for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.
Investment Analysis Report: ASND
Overview
ASND is a pharmaceutical company operating in the Health Technology sector with a market capitalization of $8.49 billion. The company's industry focus is on Pharmaceuticals: Major. In this report, we will conduct a comprehensive analysis of ASND's financial statements over the past three years to evaluat...
Technical Analysis of ASND 2024-05-03
Overview:
In analyzing the technical indicators for ASND over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...
Recent News & Updates
- 2024-05-06 09:59
- 2024-05-04 09:07
- 2024-05-03 03:49
Ascendis Pharma Q1 Net Loss Widens, Revenue Rises(MT Newswires)
- 2024-05-02 16:01
Ascendis Pharma Reports First Quarter 2024 Financial Results(GlobeNewswire)
- 2024-05-02 09:57
- 2024-05-02 04:01
Ascendis Pharma Reports First Quarter 2024 Financial Results(Globenewswire)
- 2024-04-25 16:46
- 2024-04-25 04:46
- 2024-04-24 11:33
- 2024-04-24 08:34
- 2024-04-24 08:30
- 2024-04-23 20:34
- 2024-04-23 20:30
- 2024-04-02 06:13
Biotech With 520% Sales Growth Nears Next Buy Point(Investor's Business Daily)
- 2024-03-22 12:09
Two Health Care Stocks Outperform S&P 500, Offer Entries(Investor's Business Daily)
- 2024-03-22 09:40
- 2024-03-22 07:47
- 2024-03-22 05:27
Ascendis Pharma A/S (ASND) Rose on Positive Trial Results(Insider Monkey)
- 2024-03-21 17:27
Ascendis Pharma A/S (ASND) Rose on Positive Trial Results(Insidermonkey)
- 2024-03-17 08:50
30 Biggest Biotechnology Companies in the World(Insider Monkey)
- 2024-03-16 20:50
30 Biggest Biotechnology Companies in the World(Insidermonkey)
- 2024-03-11 10:36
- 2024-03-08 07:31
- 2024-03-07 08:14
Ascendis Pharma A/S (ASND) Faced R&D Setbacks in Q4(Insider Monkey)
- 2024-03-06 19:14
Ascendis Pharma A/S (ASND) Faced R&D Setbacks in Q4(Insidermonkey)
- 2024-03-06 09:40
- 2024-03-04 08:30
- 2024-03-03 19:30
- 2024-02-15 12:00
- 2024-02-15 09:40
Page 1 of 6
previousnext